Navigation Links
Case Zeltiq - CLINIPRO: The Court Upholds Clinipro - LipoCryo Claim
Date:1/29/2013

BARCELONA, Spain, January 29, 2013 /PRNewswire/ --

CLINIPRO, a Spanish company that manufactures medical-aesthetical devices, announces that the Barcelona Trade Court No. 5 has dictated a resolution, dated January 25th, 2013, fully disregarding the lawsuit promoted by Zeltiq Aesthetics Inc. (Nasdaq: ZLTQ) and Massachusetts General Hospital (MGH) against CLINIPRO, for alleged infringements of patents and disloyal competence acts. The matter has been carried out by the SOL MUNTAÑOLA & ASOCIADOS office, which CLINIPRO put in charge of the legal management.

The sentence states that the patents of the plaintiffs are annulated, due to the lack of inventive activity (the procedure patent) and to the lack of new items (the device patent), so that the presented claim is refused. Moreover, the sentence denies the disloyal acts existence, also a part of the claim, among other reasons, because Zeltiq and MGH cannot appropriate themselves of the name that describes the cold-application technique used to reduce fat (cryolipolysis). The sentence imposes on Zeltiq and MGH the payment of the costs incurred, although CLINIPRO is considering the possibility of requesting, also, the damages and prejudices caused.

We must recall that, due to the claim presented by MGH and Zeltiq against CLINIPRO for copyrights violation, a preliminary order was dictated on May 5th, 2012, where cautionary measures were taken against marketing LipoCryo in Spain. Later, those measures were declared without effect by means of a sentence dated June 25th, 2012, the court accepting the deposit of a substitutive caution. Now, by this new sentence, the caution measures have been immediately cancelled.

SOL MUNTAÑOLA ABOGADOS, in charge of defending CLINIPRO in this matter, expressed their satisfaction: "The sentence is clear and to the point, so that there is no doubt about the lawfulness of Lipocryo," has said Mario Sol , the firm's founding partner and one of the lawyers that was in charge of this case.

About CLINIPRO

Clinipro is a company with presence in over 40 countries and its vision is to remain being the benchmark and the effective, secure and non-invasive alternative to surgical treatments of aesthetic medicine. Always aimed at offering the latest technology and staying ahead of market trends to provide the most innovative technologies. Clinipro, with 20 years of industry experience, has professional technicians and highly qualified physicians that support their brands results such as LipoCryo and Mesostar, among others, which contribute to people's physical well being through safe and effective procedures.

More information
Fermín San Martín
fsanmartin@clinipro.net
+34-935-903-108


'/>"/>
SOURCE Clinipro S.L
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. 3M Withdraws Blackmail Claims Against Harvey Boulter From New York Court
2. Intellectual Property Lawyer Available for Comment on Recent Supreme Court Ruling
3. California Healthcare Institute Issues Statement on Supreme Court Ruling on the Affordable Care Act
4. Medzilla.com Special Report: Unemployed Can Breathe a Little Freer After Supreme Court's Affordable Care Act Ruling
5. K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy Court
6. K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy Court
7. AspenBio Announces Dismissal of Class Action and Chipman Lawsuits by U. S. District Court
8. Appeal Courts Direction on Claim Construction Is Strategically Important for Butamaxs Case Against Gevo Scheduled for April 2013
9. Three Blockbuster Patent Cases at the Supreme Court This Term
10. Why Medicare Carrier Proposes Major Changes in the Handling of Code Stacked Molecular Test Claims is Topic of December 20 Audio Conference
11. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... Cynvenio Biosystems, ... launch of a new neoadjuvant breast cancer monitoring (NEAT) study in partnership with Allentown, ... centers and over 150 patients to be monitored over two years with Cynvenio’s ClearID ...
(Date:4/27/2017)... ... April 27, 2017 , ... Oncolinx, a spin-out of the ... has truly taken their cancer research out of this world. On April 22, ... Canaveral to the International Space Station’s (ISS) U.S. National Laboratory, managed by the ...
(Date:4/27/2017)... ... April 27, 2017 , ... Arrowhead Publishers is pleased ... is coming to San Diego, CA on September 27-28, 2017. Leaders from the ... latest advances in the treatment of various types of pain. There are also ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... joined other scientists, researchers, engineers, and industry professionals in visiting U.S. Congressional offices ... to compete in the world photonics industry. , This year, National Photonics ...
Breaking Biology Technology:
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
(Date:4/11/2017)... Apr. 11, 2017 Research and Markets has ... report to their offering. ... The global eye tracking market to grow at a CAGR of ... Eye Tracking Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
Breaking Biology News(10 mins):